Everybody nose: molecular and clinical characteristics of nasal colonization during active methicillin-resistant Staphylococcus aureus bloodstream infection - BMC Infectious Diseases - BMC Infectious Diseases

  • Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520–32.

    CAS  Article  Google Scholar 

  • Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7(9):629–41.

    CAS  Article  Google Scholar 

  • Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5(12):751–62.

    Article  Google Scholar 

  • Muthukrishnan G, Lamers RP, Ellis A, Paramanandam V, Persaud AB, Tafur S, et al. Longitudinal genetic analyses of Staphylococcus aureus nasal carriage dynamics in a diverse population. BMC Infect Dis. 2013;13:221.

    Article  Google Scholar 

  • VandenBergh MF, Yzerman EP, van Belkum A, Boelens HA, Sijmons M, Verbrugh HA. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol. 1999;37(10):3133–40.

    CAS  Article  Google Scholar 

  • Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10(3):505–20.

    CAS  Article  Google Scholar 

  • Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004;39(6):776–82.

    Article  Google Scholar 

  • Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004;364(9435):703–5.

    Article  Google Scholar 

  • Cespedes C, Said-Salim B, Miller M, Lo SH, Kreiswirth BN, Gordon RJ, et al. The clonality of Staphylococcus aureus nasal carriage. J Infect Dis. 2005;191(3):444–52.

    Article  Google Scholar 

  • von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 2001;344(1):11–6.

    Article  Google Scholar 

  • Berbel Caban A, Pak TR, Obla A, Dupper AC, Chacko KI, Fox L, et al. PathoSPOT genomic epidemiology reveals under-the-radar nosocomial outbreaks. Genome Med. 2020;12(1):96.

    CAS  Article  Google Scholar 

  • Senn L, Clerc O, Zanetti G, Basset P, Prod'hom G, Gordon NC, et al. The stealthy superbug: the role of asymptomatic enteric carriage in maintaining a long-term hospital outbreak of ST228 methicillin-resistant Staphylococcus aureus. MBio. 2016;7(1):e02039-e2115.

    CAS  Article  Google Scholar 

  • Dupper AC, Sullivan MJ, Chacko KI, Mishkin A, Ciferri B, Kumaresh A, et al. Blurred molecular epidemiological lines between the two dominant methicillin-resistant Staphylococcus aureus clones. Open Forum Infect Dis. 2019;6(9):ofz302.

    Article  Google Scholar 

  • Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis. 2006;42(5):647–56.

    CAS  Article  Google Scholar 

  • Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis. 2008;46(6):787–94.

    Article  Google Scholar 

  • Lederberg J, Lederberg EM. Replica plating and indirect selection of bacterial mutants. J Bacteriol. 1952;63(3):399–406.

    CAS  Article  Google Scholar 

  • Pardos de la Gandara M, Raygoza Garay JA, Mwangi M, Tobin JN, Tsang A, Khalida C, et al. Molecular types of methicillin-resistant Staphylococcus aureus and methicillin-sensitive S. aureus strains causing skin and soft tissue infections and nasal colonization, identified in Community Health Centers in New York City. J Clin Microbiol. 2015;53(8):2648–58.

    Article  Google Scholar 

  • Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018;3:124.

    Article  Google Scholar 

  • Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.

    Article  Google Scholar 

  • CDC. Multidrug-Resistant Organisms & Clostrioides difficile Infection (MDRO/CDI) Module. 2018.

  • Base SAS 9.4 Procedures Guide: Statistical Procedures: SAS Institute Inc. SAS Institute; 2013.

  • Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J Infect Dis. 2008;197(9):1226–34.

    Article  Google Scholar 

  • Humphreys H, Fitzpatick F, Harvey BJ. Gender differences in rates of carriage and bloodstream infection caused by methicillin-resistant Staphylococcus aureus: are they real, do they matter and why? Clin Infect Dis. 2015;61(11):1708–14.

    CAS  PubMed  Google Scholar 

  • Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244–53.

    CAS  Article  Google Scholar 

  • Mongkolrattanothai K, Gray BM, Mankin P, Stanfill AB, Pearl RH, Wallace LJ, et al. Simultaneous carriage of multiple genotypes of Staphylococcus aureus in children. J Med Microbiol. 2011;60(Pt 3):317–22.

    CAS  Article  Google Scholar 

  • Paterson GK, Harrison EM, Murray GGR, Welch JJ, Warland JH, Holden MTG, et al. Capturing the cloud of diversity reveals complexity and heterogeneity of MRSA carriage, infection and transmission. Nat Commun. 2015;6:6560.

    CAS  Article  Google Scholar 

  • DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet. 2010;375(9725):1557–68.

    Article  Google Scholar 

  • Zacharioudakis IM, Zervou FN, Ziakas PD, Mylonakis E. Meta-analysis of methicillin-resistant Staphylococcus aureus colonization and risk of infection in dialysis patients. J Am Soc Nephrol. 2014;25(9):2131–41.

    CAS  Article  Google Scholar 

  • Didelot X, Walker AS, Peto TE, Crook DW, Wilson DJ. Within-host evolution of bacterial pathogens. Nat Rev Microbiol. 2016;14(3):150–62.

    CAS  Article  Google Scholar 

  • Kourtis AP, Hatfield K, Baggs J, Mu Y, See I, Epson E, et al. Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections—United States. MMWR Morb Mortal Wkly Rep. 2019;68(9):214–9.

    Article  Google Scholar 

    • -

    Comments

    Post a Comment

    Popular Posts

    UKHSA Advisory Board: preparedness for infectious disease threats

    Image
    pneumo :: Article Creator How Often Do You Need To Get A Pneumonia Shot? The pneumonia shot is a vaccine that helps protect you against pneumococcal disease, or diseases caused by bacteria known as Streptococcus pneumoniae. The vaccine can help protect you from pneumococcal disease for many years. One of the most common causes of pneumonia is infection of the lungs with the bacteria Streptococcus pneumoniae. These bacteria mainly affect your lungs and can cause sometimes life-threatening infections in other parts of your body, too, including the bloodstream (bacteremia), or brain and spine (meningitis). The pneumonia shot is especially recommended if you fall into one of these age groups: Younger than 2 years old: four shots (at 2 months, 4 months, 6 months, and then a booster between 12 and 15 months) 65 years old or older: two shots, which will last you the rest of your life Between 2 and 64 years old: between one and thr...
    Read more